Boundless Bio, Inc. Stock Analysis & AI Score
Boundless Bio, Inc. (BOLD) has an ST Score of 47.1 (C+), driven by its Financial Strength (A) and held back by its Profitability (D-). BOLD last traded at $2.60.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Boundless Bio, Inc. (BOLD) has an ST Score of 47.1 (C+), driven by its Financial Strength (A) and held back by its Profitability (D-). BOLD last traded at $2.60.
- Strongest
- Financial StrengthA
- Weakest
- ProfitabilityD-
All factor grades
- Financial StrengthA
- MomentumA-
- ValuationB
- GrowthC-
- ProfitabilityD-
- Piotroski1/9
Contact
BOLD stock: frequently asked questions
What is BOLD's ST Score?
Boundless Bio, Inc. (BOLD) has an ST Score of 47.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BOLD a buy, hold, or sell?
Our ST Score grades it C+ (47.1/100). The ST Score is a data-driven signal, not a recommendation.
What are BOLD's factor grades?
Valuation B, Profitability D-, Financial Strength A, Momentum A-, Growth C-.
What is BOLD's valuation grade?
Boundless Bio, Inc. (BOLD) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BOLD's growth grade?
Boundless Bio, Inc. (BOLD) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BOLD's profitability grade?
Boundless Bio, Inc. (BOLD) earns a profitability grade of D-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BOLD's financial strength grade?
Boundless Bio, Inc. (BOLD) earns a financial strength grade of A, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BOLD's Piotroski score?
Boundless Bio, Inc. (BOLD) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.